These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Characterization of a single base-pair deletion in neurofibromatosis type 1. Colman SD; Collins FS; Wallace MR Hum Mol Genet; 1993 Oct; 2(10):1709-11. PubMed ID: 8268926 [TBL] [Abstract][Full Text] [Related]
43. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis. Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172 [TBL] [Abstract][Full Text] [Related]
44. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786 [TBL] [Abstract][Full Text] [Related]
45. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain. Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707 [TBL] [Abstract][Full Text] [Related]
46. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Stephens K; Kayes L; Riccardi VM; Rising M; Sybert VP; Pagon RA Hum Genet; 1992 Jan; 88(3):279-82. PubMed ID: 1346385 [TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. Kehrer-Sawatzki H; Tinschert S; Jenne DE J Med Genet; 2003 Oct; 40(10):e116. PubMed ID: 14569139 [No Abstract] [Full Text] [Related]
48. Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36. Chen YZ; Soeda E; Yang HW; Takita J; Chai L; Horii A; Inazawa J; Ohki M; Hayashi Y Genes Chromosomes Cancer; 2001 Aug; 31(4):326-32. PubMed ID: 11433523 [TBL] [Abstract][Full Text] [Related]
49. Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1). Lothe RA; Saeter G; Danielsen HE; Stenwig AE; Høyheim B; O'Connell P; Børresen AL Pathol Res Pract; 1993 May; 189(4):465-71; discussion 471-4. PubMed ID: 8351250 [TBL] [Abstract][Full Text] [Related]
50. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247 [TBL] [Abstract][Full Text] [Related]
51. A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay. Upadhyaya M; Roberts SH; Maynard J; Sorour E; Thompson PW; Vaughan M; Wilkie AO; Hughes HE J Med Genet; 1996 Feb; 33(2):148-52. PubMed ID: 8929953 [TBL] [Abstract][Full Text] [Related]
52. Evidence for the presence of the second allele of the neurofibromatosis type 1 gene in melanocytes derived from café au laitmacules of NF1 patients. Eisenbarth I; Assum G; Kaufmann D; Krone W Biochem Biophys Res Commun; 1997 Aug; 237(1):138-41. PubMed ID: 9266845 [TBL] [Abstract][Full Text] [Related]
53. Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene? Maris JM; Jensen J; Sulman EP; Beltinger CP; Allen C; Biegel JA; Brodeur GM; White PS Eur J Cancer; 1997 Oct; 33(12):1991-6. PubMed ID: 9516840 [TBL] [Abstract][Full Text] [Related]
54. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Viskochil D; Buchberg AM; Xu G; Cawthon RM; Stevens J; Wolff RK; Culver M; Carey JC; Copeland NG; Jenkins NA Cell; 1990 Jul; 62(1):187-92. PubMed ID: 1694727 [TBL] [Abstract][Full Text] [Related]
55. Detailed molecular analysis of 1p36 in neuroblastoma. White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901 [TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of four novel large deletions in the human neurofibromatosis type 1 (NF1) gene. Fang LJ; Vidaud D; Vidaud M; Thirion JP Hum Mutat; 2001 Dec; 18(6):549-50. PubMed ID: 11748857 [TBL] [Abstract][Full Text] [Related]
58. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors. Hoebeeck J; Michels E; Menten B; Van Roy N; Eggert A; Schramm A; De Preter K; Yigit N; De Smet E; De Paepe A; Laureys G; Vandesompele J; Speleman F Int J Cancer; 2007 Feb; 120(3):533-8. PubMed ID: 17096344 [TBL] [Abstract][Full Text] [Related]
59. Evidence of DNA methylation in the neurofibromatosis type 1 (NF1) gene region of 17q11.2. Rodenhiser DI; Coulter-Mackie MB; Singh SM Hum Mol Genet; 1993 Apr; 2(4):439-44. PubMed ID: 8504305 [TBL] [Abstract][Full Text] [Related]
60. A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. Vandepoele K; Andries V; Van Roy N; Staes K; Vandesompele J; Laureys G; De Smet E; Berx G; Speleman F; van Roy F PLoS One; 2008 May; 3(5):e2207. PubMed ID: 18493581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]